New obesity drug aims to curb appetite and cut calories
NCT ID NCT07557953
First seen May 14, 2026 · Last updated May 16, 2026 · Updated 2 times
Summary
This study tests a medicine called cagrilintide to see how it changes appetite and how much people eat. About 120 adults with overweight or obesity will get either the drug or a placebo for around 30 weeks. The main goal is to measure the change in total calories eaten during meals and snacks.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Parexel International GmbH
RECRUITINGBerlin, 14050, Germany
Conditions
Explore the condition pages connected to this study.